Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Previous positron emission tomography (PET) studies have provided evidence that the psychological expectation of certain drugs combined to the placebo administration may lead to subjectively experienced placebo effects, which, in turn, are associated with dopamine (DA) release in the brain. Our recent study indicated that blind intravenous (i.v.) glucose induces DA release in male subjects. In the present study, we examined if the mere expectation of glucose (i.v. placebo) could similarly release DA in the basal ganglia. [11 C]raclopride PET was performed for 12 lean [mean body mass index (BMI) = 22 kg/m 2] and 12 overweight (mean BMI = 33 kg/m 2) healthy subjects (12 men and 12 women). Each subject was imaged twice in a counter‐balanced setting, after blind i.v. placebo and after open i.v. placebo. DA D2 receptor binding potentials (BP) were estimated. The results of the present study show that i.v. placebo administration with glucose expectation induces bilateral BP reduction in the ventral striatum in the male group, suggesting DA release. The stimulus did not induce dopaminergic placebo effect in the overweight or the lean group (males and females combined). Voxel‐based analysis also suggested regionally selective BP increases in the dorsal striatum in the male subjects, whereas women showed no significant changes in BPs. The results support previously reported gender differences in the DA function after a pharmacological challenge (e.g., amphetamine and glucose). Also, they suggest that the DA release in the ventral striatum mediates placebo responses in the context of glucose expectation. Synapse 62:682–688, 2008. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · cited 1×
“However, there is evidence that the availability of brain DA D2 receptors of overweight individuals is decreased in proportion to their body mass index (BMI) (Haltia et al., 2007; Wang et al., 2001).”
BackgroundPlacebo and Opioid Analgesia-- Imaging a Shared Neuronal Network
Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002) · Science · doi:10.1126/science.1067176 · Cited by 1,488 · cited 2×
“Other PET studies have shown that placebo treatments can induce clinically relevant neurobiological responses in patients with Parkinson’s disease (de la Fuente-Fernández et al., 2001), depression (Mayberg et al., 2002) and pain (Petrovic et al., 2002).”
BackgroundSmall, D. M., Jones-Gotman, M., & Dagher, A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00253-2 · Cited by 632
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452 · cited 1×
“Eating, and also display of food without consumption, has been reported to induce DA release in the brain (Small et al., 2003; Volkow et al., 2002), but the underlying mechanisms of DA release are unclear.”
BackgroundBoileau, I., Dagher, A., Leyton, M., Welfeld, K., Booij, L., Diksic, M., & Benkelfat, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4370-06.2007 · Cited by 222 · cited 3×
“Another [(11)C]raclopride PET study examined dopaminergic placebo effect after amphetamine conditioning (Boileau et al., 2007).”
BackgroundEffects of intravenous glucose on dopaminergic function in the human brain in vivo
Haltia, L. T., Rinne, J. O., Merisaari, H., Maguire, R. P., Savontaus, E., Helin, S., Någren, K., & Kaasinen, V. (2007) · Synapse · doi:10.1002/syn.20418 · Cited by 148 · cited 14×
“The blind glucose vs. blind placebo results were published in our previous paper (Haltia et al., 2007), and the open placebo vs. blind placebo results are reported here.”
BackgroundMethodResultInfluentialSelf-citation
Cited by
Schweinhardt, P., Seminowicz, D. A., Jaeger, E., Duncan, G. H., & Bushnell, M. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5634-08.2009 · Cited by 210
“Thirdly, our interpretation might only apply to male subjects, since the dopaminergic system differs between genders, also with respect to expectation-induced dopamine release (Haltia et al., 2008).”
BackgroundNeural vulnerability factors that increase risk for future weight gain
Stice, E., & Yokum, S. (2016) · Psychological Bulletin · doi:10.1037/bul0000044 · Cited by 179
“, 2008), though other studies have not replicated this finding (Eisenstein et al., 2013; Haltia et al., 2008; Karlsson et al., 2015; Steele et al., 2010).”
BackgroundResultClassical conditioning of antidepressant placebo effects in mice
Krimmel, S. R., Zanos, P., Georgiou, P., Colloca, L., & Gould, T. D. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05347-4 · Cited by 12
Metadata
- Authors
- Haltia, L. T., Rinne, J. O., Helin, S., Parkkola, R., Någren, K., & Kaasinen, V.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2008-06-24
- Volume
- 62
- Issue
- 9
- Pages
- 682-688
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2028154435
- Cited by
- 39
- References
- 7
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.